Ann: PhytoTech Therapeutics Limited Operations Update, page-2

I don’t know but this doesn’t sound encouraging at all.

The language suggests a collaboration or a stake sale as Satipharm are not capable of bringing it to market any time soon?

A collaboration would just be placing the research on further life support for an indefinite period.

A stake sale to a more established Pharma may be positive as it would then put a tangible value to the patents and research done. Either way it means revenue from this Avenue is not going to be coming for awhile